US › Healthcare

AngioDynamics Inc (ANGO)

US · Healthcare · Medical Instruments & Supplies

$15.19+0.13%
Last close · 2026-08-04

Latest quarter · ended 2026-05-31

Revenue
$86.6M
Revenue YoY
+8.0%
Net profit
$-11.4M
Profit YoY
-88.5%
EPS
$-0.07
EPS estimate
$-0.11
Net margin
-13.2%

EPS came in at -0.07 against a street estimate of -0.11 — a beat of 36.4%.

Key statistics

Market cap
$627.0M
Forward P/E
208.3
P/B
3.58
Book value
$4.10
EPS (TTM)
$-0.88
52-week high
$15.41
52-week low
$8.36
50-day MA
$12.78
200-day MA
$11.78
Beta
0.32

Analyst view

Analysts rate AngioDynamics Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $20.00.

Shareholding

Insiders
12.71%
Institutions
94.56%

Largest institutional holders

FundStake
BlackRock Inc8.84%
Point72 Asset Management, L.P.7.63%
Systematic Financial Management LP5.88%
Vanguard Group Inc5.84%
Broadfin Holdings LLC4.96%
Armistice Capital, LLC4.48%
Vanguard Capital Management, LLC4.14%
Royce & Associates, LP3.67%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for AngioDynamics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.